Cargando…
Integrating the Neurobiology of Schizophrenia /
A thorough overview of all neurotransmitters involved in schizophrenia.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; Boston :
Elsevier,
2007.
|
| Colección: | International review of neurobiology ;
v. 78. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn137276169 | ||
| 003 | OCoLC | ||
| 005 | 20231117014733.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 070531s2007 ne a ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d QCL |d MERUC |d E7B |d OCLCQ |d IDEBK |d OCLCQ |d OPELS |d OCLCQ |d OPELS |d CUS |d OCLCF |d OCLCQ |d YDXCP |d NRU |d OCLCQ |d MEU |d FEM |d D6H |d VT2 |d NLE |d UKMGB |d OCLCA |d LEAUB |d OCLCQ |d WURST |d INARC |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 015 | |a GBA727341 |2 bnb | ||
| 015 | |a GBB6H3704 |2 bnb | ||
| 016 | 7 | |a 013708606 |2 Uk | |
| 016 | 7 | |a 017581679 |2 Uk | |
| 019 | |a 123797281 |a 441777091 |a 648219575 |a 703858029 |a 968011660 |a 969081004 |a 1050956124 |a 1176180810 | ||
| 020 | |a 9780080475080 |q (electronic bk.) | ||
| 020 | |a 0080475086 |q (electronic bk.) | ||
| 020 | |a 0123737370 |q (electronic bk.) | ||
| 020 | |a 9780123737373 |q (electronic bk.) | ||
| 035 | |a (OCoLC)137276169 |z (OCoLC)123797281 |z (OCoLC)441777091 |z (OCoLC)648219575 |z (OCoLC)703858029 |z (OCoLC)968011660 |z (OCoLC)969081004 |z (OCoLC)1050956124 |z (OCoLC)1176180810 | ||
| 050 | 4 | |a RC341 |b .I5 2007eb | |
| 072 | 7 | |a PSY |x 022050 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.898 |2 22 |
| 245 | 0 | 0 | |a Integrating the Neurobiology of Schizophrenia / |c edited by Anissa Abi-Dargham, Olivier Guillin. |
| 264 | 1 | |a Amsterdam ; |a Boston : |b Elsevier, |c 2007. | |
| 300 | |a 1 online resource (xvi, 459 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a International review of neurobiology ; |v v. 78 | |
| 546 | |a Text in English. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Cover -- Copyright Page -- Contents -- Contributors -- Preface -- References -- Chapter 1: Neurobiology of Dopamine in Schizophrenia -- I. Introduction -- II. Dopaminergic System in the Brain -- A. Dopaminergic Projections -- B. Dopaminergic Receptors -- III. Evidence Supporting Alterations of DA Systems in Schizophrenia -- A. Pharmacological Evidence -- B. Postmortem Studies -- C. Imaging Studies -- IV. Conclusions -- References -- Chapter 2: The Dopamine System and the Pathophysiology of Schizophrenia: A Basic Science Perspective -- I. Introduction -- II. Neuroanatomy of DA Systems -- III. DA Neuron Activity and Release -- IV. Cellular Actions of DA -- V. Roles of DA on Cognitive and Affective Functions -- VI. Development and Maturation of the DA System -- VII. DA Deficits in Schizophrenia -- VIII. Conclusions -- References -- Chapter 3: Glutamate and Schizophrenia: Phencyclidine, N-Methyl-D-Aspartate Receptors, and Dopamine-Glutamate Interactions -- I. Introduction -- II. Glutamatergic Physiology -- A. Glutamate-Dopamine Comparisons -- B. Glutamate Receptors -- C. NMDA Receptors -- D. AMPA/Kainate Receptors -- E. Metabotropic Receptors -- III. Glutamatergic Models of Schizophrenia -- A. Symptom Patterns Following NMDA Antagonist Administration -- B. Cognitive Deficits Following NMDA Antagonist Treatment -- C. In Vivo Findings in Schizophrenia Based on Dopamine Receptor Occupancy -- D. Postmortem Findings -- IV. Clinical Studies with NMDA Agonists -- A. NMDA Receptor Glycine-Site Agonists -- B. Glycine Transport Inhibitors -- C. Other Ionotropic Targets -- D. Metabotropic Receptors -- E. Group I Receptors -- F. Group II Metabotropic Agonists -- V. Potential Causes of Glutamatergic Dysfunction in Schizophrenia -- A. Dopamine-Glutamate Interactions -- B. Linkage-Association Studies in Schizophrenia -- C. Environmental and Neurochemical Factors -- VI. Future Research and Treatment Implications -- Acknowledgments -- References -- Chapter 4: Deciphering the Disease Process of Schizophrenia: the. Contribution of Cortical Gaba Neurons -- I. Working Memory Impairments: A Core Feature of Schizophrenia -- II. Working Memory Impairments and Altered GABA Neurotransmission in the DLPFC -- III. Potential Pathogenetic Mechanisms for Cell Type-Specific Alterations in GABA Neurons -- A. Reduced Excitatory Drive via NMDA Receptors -- B. Reduced Neurotrophin Signaling -- IV. Connecting Alterations in PV-Positive Neurons to Working Memory Impairments: Decreased Gamma Band Synchrony in Schizophrenia -- V. Treatment Implications -- Acknowledgments -- References -- Chapter 5: Alterations of Serotonin Transmission in Schizophrenia -- I. Introduction -- II. Alteration of 5-HT Receptors in Schizophrenia -- A. 5-HT Transporters -- B. 5-HT1A Receptors -- C. 5-HT2 Receptors -- D. Other Receptors -- III. Pharmacological Manipulation of 5-HT Transmission in Schizophrenia -- A. 5-HT Precursors -- B. 5-HT Depleting Agents -- C. 5-HT2A Agonism: LSD and "Model. | |
| 520 | |a A thorough overview of all neurotransmitters involved in schizophrenia. | ||
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Schizophrenia |x Physiological aspects. | |
| 650 | 0 | |a Schizophrenia |x Chemotherapy. | |
| 650 | 2 | |a Schizophrenia |x drug therapy |0 (DNLM)D012559Q000188 | |
| 650 | 2 | |a Schizophrenia |x physiopathology |0 (DNLM)D012559Q000503 | |
| 650 | 6 | |a Schizophr�enie |x Chimioth�erapie. |0 (CaQQLa)201-0020954 | |
| 650 | 7 | |a PSYCHOLOGY |x Psychopathology |x Schizophrenia. |2 bisacsh | |
| 650 | 7 | |a Schizophrenia |x Chemotherapy |2 fast |0 (OCoLC)fst01106753 | |
| 650 | 7 | |a Schizophrenia |x Physiological aspects |2 fast |0 (OCoLC)fst01106768 | |
| 653 | 0 | 0 | |a schizofrenie |
| 653 | 0 | 0 | |a schizophrenia |
| 653 | 0 | 0 | |a geestelijke stoornissen |
| 653 | 0 | 0 | |a mental disorders |
| 653 | 0 | 0 | |a neurofysiologie |
| 653 | 0 | 0 | |a neurophysiology |
| 653 | 0 | 0 | |a neurologie |
| 653 | 0 | 0 | |a neurology |
| 653 | 0 | 0 | |a neurotransmitters |
| 653 | 0 | 0 | |a cannabinoids |
| 653 | 0 | 0 | |a neurobiologie |
| 653 | 0 | 0 | |a neurobiology |
| 653 | 1 | 0 | |a Human Pathology |
| 653 | 2 | 0 | |a Neurophysiology |
| 653 | 1 | 0 | |a Humane pathologie |
| 653 | 2 | 0 | |a Neurofysiologie |
| 700 | 1 | |a Abi-Dargham, Anissa, |e editor. | |
| 700 | 1 | |a Guillin, Olivier, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Integrating the neurobiology of schizophrenia. |d Amsterdam ; Boston : Elsevier, �2007 |z 0123737370 |z 9780123737373 |w (OCoLC)122378591 |
| 830 | 0 | |a International review of neurobiology ; |v v. 78. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780123737373 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00747742/78 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00747742 |z Texto completo |